Stuart Burgess, MD
Retina Specialist · Plantation, FLNPI 1689676363
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.8%), travel and lodging and ownership interests — rather than concentrated in one kind of arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 12.5%. Reporting peaked in 2024 at $6,392 and has fallen 75.8% since, to $1,548 in 2025.
Across 225 payments — averaging $81.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2K
- Eyepoint US, Inc.$2K
- Kyowa Kirin, Inc.$2K
- US Retina LLC$2K
- Genentech USA, Inc.$2K
- Cardinal Health 108 LLC$2K
- plus $7K from 30 others
Across 500 payments — averaging $9169.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$3.6M
- Kyowa Kirin, Inc.$344K
- Bayer$294K
- Hexal AG$143K
- Regeneron$109K
- Janssen Research & Development, LLC$32K
- plus $34K from 3 others
What the payments were for
- Consulting fees$1,7259%
- Travel & lodging$5,38429%
- Food & beverage$9,34351%
- Ownership interest$1,92610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 8 | $2,293 |
| Eyepoint US, Inc. | 4 | $2,029 |
| Kyowa Kirin, Inc. | 8 | $1,948 |
| US Retina LLC | 5 | $1,926 |
| Genentech USA, Inc. | 49 | $1,608 |
| Cardinal Health 108 LLC | 1 | $1,575 |
| US Oncology Corporate, Inc. | 6 | $1,476 |
| AbbVie(2 entities) | 28 | $1,193 |
| Regeneron Healthcare Solutions, Inc. | 29 | $961 |
| Astellas Pharma US Inc | 12 | $711 |
| Regeneron | 3 | $399 |
| Apellis Pharmaceuticals, Inc. | 10 | $274 |
| Amgen(2 entities) | 13 | $257 |
| Harrow Eye, LLC | 9 | $239 |
| NEW World Medical,inc. | 1 | $176 |
| Cardinal Health 110 LLC | 1 | $150 |
| Alcon | 2 | $137 |
| Biotissue Holdings Inc. | 1 | $119 |
| Optos, Inc. | 1 | $99 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $97 |
| Alimera Sciences, Inc. | 5 | $93 |
| Novartis | 5 | $87 |
| Sandoz | 3 | $80 |
| ANI Pharmaceuticals, Inc. | 3 | $71 |
| Notal Vision, Inc. | 3 | $68 |
| Optovue, Inc. | 1 | $66 |
| Coherus Oncology, Inc. | 2 | $49 |
| Merz Pharmaceuticals, LLC | 2 | $43 |
| Sun Pharmaceutical Industries Inc. | 2 | $41 |
| Dompe US, Inc. | 1 | $18 |
| Rxsight Inc | 1 | $18 |
| Spark Therapeutics, Inc. | 1 | $16 |
| Kala Pharmaceuticals, Inc. | 1 | $16 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $15 |
| Aerie Pharmaceuticals, Inc. | 1 | $15 |
| Glaukos Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,377 in reported general payments places this provider in the 80th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 89 | $2,779 |
| Difluprednate | 14 | $1,675 |
| Dorzolamide Hcl | 11 | $295 |
| Ciprofloxacin Hcl | 14 | $178 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $175 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $170 |
| Latanoprost | 22 | $137 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Plantation
- Natalia VillatePlantation$9K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
- John MyersPensacola$152K
- Timothy MurraySouth Miami$133K
- Adiel SmithAventura$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.